Cracking The Code: Understanding Analyst Reviews For Stem
Portfolio Pulse from Benzinga Insights
Stem (NYSE:STEM) has received mixed analyst ratings over the past three months, with a shift towards a more cautious outlook. The average 12-month price target for STEM has been lowered to $4.05, indicating a 26.36% decrease from the previous target of $5.50. Analysts from firms including Susquehanna, Piper Sandler, BMO Capital, Goldman Sachs, and Morgan Stanley have all adjusted their ratings and price targets downwards, reflecting concerns over market conditions and company performance. Despite this, Stem's financials show a positive revenue trend with a growth rate of 34.41% as of September 30, 2023, but challenges in net margin, ROE, ROA, and a high debt-to-equity ratio.
February 29, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Stem's stock may face short-term pressure due to lowered analyst ratings and price targets, reflecting concerns over market conditions and company performance.
The lowering of price targets and ratings by multiple analysts indicates a consensus of caution towards Stem, likely influencing investor sentiment negatively in the short term. Despite positive revenue growth, the company's challenges in net margin, ROE, ROA, and high debt levels contribute to the cautious outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100